Literature DB >> 23635428

Is poststroke depression a major depression?

Carlos E da Rocha e Silva1, Marco A Alves Brasil, Emilia Matos do Nascimento, Basilio de Bragança Pereira, Charles André.   

Abstract

BACKGROUND: Poststroke depression (PSD) is the most common neuropsychiatric consequence of stroke. A large number of studies have focused on the pathogenesis of PSD, but only a few aimed to characterize its psychopathology; these studies yielded results that are difficult to compare because of the different methods utilized. The current study aimed to characterize the symptom profile of PSD in an attempt to better understand the disease and allow a more accurate diagnosis.
METHODS: The study sample comprised 64 patients divided into three groups: stroke patients without diagnosis of depression (n = 33), stroke patients diagnosed with PSD (PSD group, n = 14) and patients diagnosed with major depression (MD) but with no clinical comorbidity (MD group, n = 17). All patients were diagnosed using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). The initial diagnostic interview was complemented by the Mini Mental State Examination (MMSE), the Rankin Scale, and four scales for the assessment of the intensity of symptoms of anxiety and depression: the Beck Depression Inventory (BDI), the Hospital Anxiety and Depression General Scale (HADS), the Hamilton Depression Rating Scale (HAM-D) and the Hamilton Rating Scale for Anxiety (HAM-A). The Star Plot, a graphical method of data visualization, was used to analyze the results. The t test was used for independent samples (two-tailed analysis).
RESULTS: As measured by the BDI, HAM-D and HAM-A scales and HADS depression subscale, the average total scores of symptoms for the sample of patients diagnosed with MD without clinical comorbidity was significantly higher than that of the PSD patients (p < 0.05). Similar results were obtained by plotting the BDI data on Star Plot. The PSD patients showed mild typical depressive symptoms such as less depressed mood, anhedonia, disinterest, guilt, negative thoughts, depreciation, suicidal ideation and anxiety, when evaluated by the HAM-A scale. Moreover, the somatic symptoms of depression did not lead to increased diagnosis of major depression in stroke patients.
CONCLUSIONS: The results indicate that the PSD clinical picture comprised, in general, symptoms of mild/moderate intensity, especially those considered as pillars for the diagnosis of depression: depressed mood, loss of pleasure and lack of interest. Given the imprecision of boundaries that separate the clinical forms of depression from subclinical and nonpathological forms, or even from the concepts of demoralization and adjustment disorders, we situate PSD in a complex biopsychosocial context in which a better understanding of its psychopathological profile could provide diagnostic and therapeutic alternatives best suited to the difficult reality experienced by stroke patients.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23635428     DOI: 10.1159/000348852

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  10 in total

1.  Gender and stress in predicting depressive symptoms following stroke.

Authors:  Carolyn M Mazure; Andrea H Weinberger; Brian Pittman; Igor Sibon; Joel Swendsen
Journal:  Cerebrovasc Dis       Date:  2014-11-13       Impact factor: 2.762

Review 2.  Drugs to Enhance Motor Recovery After Stroke.

Authors:  Steven C Cramer
Journal:  Stroke       Date:  2015-08-11       Impact factor: 7.914

3.  Activation of the kynurenine pathway in the acute phase of stroke and its role in fatigue and depression following stroke.

Authors:  Heidi Ormstad; Robert Verkerk; Karl-Friedrich Amthor; Leiv Sandvik
Journal:  J Mol Neurosci       Date:  2014-03-25       Impact factor: 3.444

4.  The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region.

Authors:  Luisa Terroni; Edson Amaro; Dan V Iosifescu; Patricia Mattos; Fabio I Yamamoto; Gisela Tinone; Adriana B Conforto; Matildes Fm Sobreiro; Valeri D Guajardo; Mara Cristina S De Lucia; Ayrton C Moreira; Milberto Scaff; Claudia C Leite; Renerio Fraguas
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-03       Impact factor: 2.570

5.  Early depression screening is feasible in hospitalized stroke patients.

Authors:  Rahul R Karamchandani; Farhaan Vahidy; Suhas Bajgur; Kim Yen Thi Vu; H Alex Choi; Robert Kirk Hamilton; Mohammad H Rahbar; Sean I Savitz
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

6.  The protein and mRNA expression levels of glial cell line-derived neurotrophic factor in post stroke depression and major depressive disorder.

Authors:  Yanran Zhang; Haitang Jiang; Yingying Yue; Yingying Yin; Yuqun Zhang; Jinfeng Liang; Shenghua Li; Jun Wang; Jianxin Lu; Deqin Geng; Aiqin Wu; Yonggui Yuan
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

7.  New opinion on the subtypes of poststroke depression in Chinese stroke survivors.

Authors:  Yingying Yue; Rui Liu; Yin Cao; Yanfeng Wu; Shining Zhang; Huajie Li; Jijun Zhu; Wenhao Jiang; Aiqin Wu; Yonggui Yuan
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-06       Impact factor: 2.570

Review 8.  Neural Substrates of Poststroke Depression: Current Opinions and Methodology Trends.

Authors:  Chensheng Pan; Guo Li; Wenzhe Sun; Jinfeng Miao; Xiuli Qiu; Yan Lan; Yanyan Wang; He Wang; Zhou Zhu; Suiqiang Zhu
Journal:  Front Neurosci       Date:  2022-04-06       Impact factor: 4.677

9.  Clinical Manifestation of Depression after Stroke: Is It Different from Depression in Other Patient Populations?

Authors:  Janneke M de Man-van Ginkel; Thóra B Hafsteinsdóttir; Eline Lindeman; Mirjam I Geerlings; Diederick E Grobbee; Marieke J Schuurmans
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

10.  Factors that influence the severity of post-stroke depression.

Authors:  S Ilut; A Stan; A Blesneag; V Vacaras; S Vesa; L Fodoreanu
Journal:  J Med Life       Date:  2017 Jul-Sep
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.